|
TBCCD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.521600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.683400E-01 |
| Normal-vs-Stage2 |
9.145200E-01 |
| Normal-vs-Stage3 |
5.921600E-02 |
| Normal-vs-Stage4 |
7.471700E-02 |
| Stage1-vs-Stage2 |
4.100000E-01 |
| Stage1-vs-Stage3 |
2.743500E-03 |
| Stage1-vs-Stage4 |
7.121800E-03 |
| Stage2-vs-Stage3 |
2.390400E-01 |
| Stage2-vs-Stage4 |
2.518600E-01 |
| Stage3-vs-Stage4 |
9.965000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.874000E-01 |
| Normal-vs-AfricanAmerican |
2.686400E-01 |
| Normal-vs-Asian |
3.760400E-01 |
| Caucasian-vs-AfricanAmerican |
3.431400E-01 |
| Caucasian-vs-Asian |
2.143800E-01 |
| AfricanAmerican-vs-Asian |
1.404790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.935990E-01 |
| Normal-vs-Female |
2.848400E-01 |
| Male-vs-Female |
1.348270E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.932600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.189800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.979000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.789800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.294200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.346600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.528000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.822570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.849400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.970000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.919600E-02 |
| Normal-vs-Grade 2 |
2.886600E-01 |
| Normal-vs-Grade 3 |
3.129200E-01 |
| Normal-vs-Grade 4 |
1.715670E-02 |
| Grade 1-vs-Grade 2 |
1.436180E-01 |
| Grade 1-vs-Grade 3 |
2.252400E-02 |
| Grade 1-vs-Grade 4 |
9.520900E-03 |
| Grade 2-vs-Grade 3 |
3.085600E-02 |
| Grade 2-vs-Grade 4 |
7.388300E-04 |
| Grade 3-vs-Grade 4 |
7.567600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.602400E-03 |
| Normal-vs-ccB subtype |
1.212370E-01 |
| ccA subtype-vs-ccB subtype |
4.29790000000541E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.033800E-01 |
| Normal-vs-N1 |
6.195800E-02 |
| N0-vs-N1 |
4.132300E-02 |
|
|
